[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "fullTimeEmployees": 378, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 54, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 611000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chaime  Orlev", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 387000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eran  Nir", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 332000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon R. Knight", "age": 57, "title": "Vice President of US Commercial Operations", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 307000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris  Gorelik", "age": 42, "title": "Vice President of Business Development & Strategic Programs", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 410000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Tsur", "age": 73, "title": "Co-Founder & Independent Deputy Chairman of the Board", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nir  Livneh B.A., L.L.B.", "age": 43, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 53, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liron  Reshef", "age": 51, "title": "Vice President of Human Resources", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.25, "open": 6.33, "dayLow": 6.21, "dayHigh": 6.39, "regularMarketPreviousClose": 6.25, "regularMarketOpen": 6.33, "regularMarketDayLow": 6.21, "regularMarketDayHigh": 6.39, "beta": 0.241, "trailingPE": 27.0, "forwardPE": 19.40625, "volume": 37691, "regularMarketVolume": 37691, "averageVolume": 25487, "averageVolume10days": 67110, "averageDailyVolume10Day": 67110, "marketCap": 356947712, "fiftyTwoWeekLow": 4.08, "fiftyTwoWeekHigh": 6.53, "priceToSalesTrailing12Months": 2.3868918, "fiftyDayAverage": 5.347, "twoHundredDayAverage": 5.4083, "currency": "USD", "enterpriseValue": 327717248, "profitMargins": 0.08331, "floatShares": 8956846, "sharesOutstanding": 57479500, "sharesShort": 25709, "sharesShortPriorMonth": 43083, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.07315, "heldPercentInstitutions": 0.49208, "shortRatio": 1.72, "shortPercentOfFloat": 0.0008, "bookValue": 4.169, "priceToBook": 1.4895658, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": 12458000, "trailingEps": 0.23, "forwardEps": 0.32, "pegRatio": 4.34, "enterpriseToRevenue": 2.191, "enterpriseToEbitda": 12.903, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "KMDA", "underlyingSymbol": "KMDA", "shortName": "Kamada Ltd.", "longName": "Kamada Ltd.", "firstTradeDateEpochUtc": 1370007000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a88fd904-380d-3754-b686-3fbaf4e080d7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.21, "targetHighPrice": 18.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.0, "targetMedianPrice": 13.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 48194000, "totalCashPerShare": 0.815, "ebitda": 25398000, "totalDebt": 8745000, "quickRatio": 1.976, "currentRatio": 4.245, "totalRevenue": 149544992, "debtToEquity": 3.548, "revenuePerShare": 2.859, "returnOnAssets": 0.02616, "returnOnEquity": 0.058969997, "freeCashflow": -17656250, "operatingCashflow": 8186000, "revenueGrowth": 0.229, "grossMargins": 0.40390998, "ebitdaMargins": 0.16984, "operatingMargins": 0.107030004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-14"}]